SCHEMBL11926604

SCHEMBL11926604

CC1(C)c2ccccc2-n2c3ccc(C(=O)c4ccccc4)cc3c3cccc1c32

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.46
▸ ALDH1A1 P00352 4/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ GLA P06280 1/20 0.42
▸ ATM Q13315 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ HPGD P15428 3/20 0.39
▸ MAPT P10636 4/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ STAT3 P40763 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PTGS1 P23219 2/20 0.38
▸ CXCR1 P25024 2/20 0.38
▸ CXCR2 P25025 2/20 0.38
▸ PTGS2 P35354 2/20 0.38
▸ LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11901193 0.96 CNR2 (0.40) CNR2ALDH1A1SMN1; SMN2GLAATM
SCHEMBL11899248 0.86 CNR2 (0.41) CNR2ALDH1A1SMN1; SMN2GLAATM
SCHEMBL11929619 0.85 CNR2 (0.35) CNR2ALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL19228177 0.83 MAPT (0.32) CNR2ALDH1A1SMN1; SMN2TDP1L3MBTL1
SCHEMBL12165866 0.83 CNR2 (0.39) CNR2ALDH1A1SMN1; SMN2GLAATM
SCHEMBL11926654 0.83 CNR2 (0.38) CNR2ALDH1A1SMN1; SMN2GLAATM
SCHEMBL11926515 0.82 CNR2 (0.38) CNR2ALDH1A1SMN1; SMN2GLAATM
SCHEMBL11926659 0.81 PDK2 (0.37) CNR2ALDH1A1SMN1; SMN2GLAKDM4E
SCHEMBL11926671 0.81 CNR2 (0.37) CNR2ALDH1A1SMN1; SMN2GLAATM
SCHEMBL11926509 0.80 CNR2 (0.38) CNR2ALDH1A1SMN1; SMN2ATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785636-B2 Substituted indoloacridines for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-07-22 — — US disclosed
US-20120202997-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-08-09 — — US disclosed
US-20120202997-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202997-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES EPCAM, L1CAM, OR10J3 CNR2 3281/4885ALDH1A1 136/4885SMN1; SMN2 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback